Apolipoprotein E and alpha-1-antichymotrypsin genotypes do not predict time to psychosis in Alzheimer's disease. (Q53247598)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11936240 AND SRC:MED&resulttype=core&format=json

9 December 2019

title

Apolipoprotein E and alpha-1-antichymotrypsin genotypes do not predict time to psychosis in Alzheimer's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11936240 AND SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11936240 AND SRC:MED&resulttype=core&format=json

9 December 2019

author name string

Robert A Sweet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11936240 AND SRC:MED&resulttype=core&format=json

9 December 2019

M Ilyas Kamboh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11936240 AND SRC:MED&resulttype=core&format=json

9 December 2019

Stephen R Wisniewski

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11936240 AND SRC:MED&resulttype=core&format=json

9 December 2019

Oscar L Lopez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11936240 AND SRC:MED&resulttype=core&format=json

9 December 2019

William E Klunk

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11936240 AND SRC:MED&resulttype=core&format=json

9 December 2019

Daniel I Kaufer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11936240 AND SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11936240 AND SRC:MED&resulttype=core&format=json

Journal of Geriatric Psychiatry and Neurology

9 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11936240 AND SRC:MED&resulttype=core&format=json

9 December 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11936240 AND SRC:MED&resulttype=core&format=json

9 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11936240 AND SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

24-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11936240 AND SRC:MED&resulttype=core&format=json

Overview of depression and psychosis in Alzheimer's disease

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Noncognitive Disturbances in Alzheimer's Disease: Frequency, Longitudinal Course, and Relationship to Cognitive Symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

The course of psychopathologic features in mild to moderate Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Incidence of and risk factors for hallucinations and delusions in patients with probable AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Predictors of disease course in patients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Cognitive deficits of patients with Alzheimer's disease with and without delusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Predictors of cognitive and functional progression in patients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Risk of mortality and institutionalization in demented patients with delusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Psychotic symptoms in dementia and the rate of cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Hallucinations and associated factors in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Clinical variables associated with psychosis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

The apolipoprotein E epsilon 4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Factors associated with psychotic symptoms in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Psychotic symptoms and apolipoprotein E genotypes in an elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Depression, delusions, and hallucinations in Alzheimer's disease: no relationship to apolipoprotein E genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

alpha 1-Antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Alpha-antichymotrypsin gene polymorphism and risk for Alzheimer's disease in the Spanish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

No interaction between the APOE and the alpha-1-antichymotrypsin genes on risk for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

No genetic effect of alpha1-antichymotrypsin in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

The natural history of Alzheimer's disease. Description of study cohort and accuracy of diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Alterations of striatal dopamine receptor binding in Alzheimer disease are associated with Lewy body pathology and antemortem psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Neuropathologic and neurochemical correlates of psychosis in primary dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Neuropathological correlates of psychotic phenomena in confirmed Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Psychotic symptoms in Alzheimer's disease are not associated with more severe neuropathologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

Apolipoprotein E and ?1-antichymotrypsin polymorphism in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/089198870201500106

10.1177/089198870201500106

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11936240 AND SRC:MED&resulttype=core&format=json

release_h7odpu2b7fbcvbkc2w3kpxpvya

9 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/h7odpu2b7fbcvbkc2w3kpxpvya

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference